Decreased vonWillebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting

European Journal of Cardio-thoracic Surgery

Volumn 45, Issue 2, 2014, Pages

  Mazur, Piotr ^a,b   Plicner, Dariusz ^a,b   Zdziarska, Joanna ^a   Sadowski, Jerzy ^a,b   Undas, Anetta ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

ADAMTS13; Chest tube drainage; Coronary artery bypass grafting; Von Willebrand factor

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN; RISTOCETIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TEST; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SUCTION DRAINAGE; BLOOD; CHEST TUBE; CHEST-TUBE DRAINAGE; COHORT ANALYSIS; METABOLISM; METHODOLOGY; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; STATISTICAL MODEL; WOUND DRAINAGE;

ADAMTS13; CHEST-TUBE DRAINAGE; CORONARY ARTERY BYPASS GRAFTING; VON WILLEBRAND FACTOR;

ADAM PROTEINS; AGED; CHEST TUBES; COHORT STUDIES; CORONARY ARTERY BYPASS; DRAINAGE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; VON WILLEBRAND FACTOR;

EID: 84892554593     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt527     Document Type: Article

References (25)

1. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-62.
2. Christensen MC, Dziewior F, Kempel A, von Heymann C. Increased chest tube drainage is independently associated with adverse outcome after cardiac surgery. J Cardiothorac Vasc Anesth 2012;26:46-51.
3. Herwaldt LA, Swartzendruber SK, Edmond MB, Embrey RP, Wilkerson KR, Wenzel RP et al. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol 1998;19:9-16.
4. Koch CG, Li L, Duncan AI, Mihaljevic T, Loop FD, Starr NJ et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006;81:1650-7.
5. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001;72:S1821-31.
6. Blome M, Isgro F, Kiessling AH, Skuras J, Haubelt H, Hellstern P et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005;93:1101-7.
7. Hartmann M, Sucker C, Boehm O, Koch A, Loer S, Zacharowski K. Effects of cardiac surgery on hemostasis. Transfus Med Rev 2006;20:230-41.
8. Firanescu CE, Martens EJ, Schonberger JP, Soliman Hamad MA, van Straten AH. Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. Eur J Cardiothorac Surg 2009; 36:856-62.
9. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11:815-23.
10. Gravlee GP, Arora S, Lavender SW, Mills SA, Hudspeth AS, Cordell AR et al. Predictive value of blood clotting tests in cardiac surgical patients. Ann Thorac Surg 1994;58:216-21.
11. Vuylsteke A, Pagel C, Gerrard C, Reddy B, Nashef S, Aldam P et al. The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding. Eur J Cardiothorac Surg 2011;39:924-30.
12. Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E et al. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 2008;111:3540-5.
13. Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 1998;67:395-424.
14. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM. Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 1990;87:6306-10.
15. Mannucci PM, Parolari A, Canciani MT, Alemanni F, Camera M. Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery. J Thromb Haemost 2005;3:397-9.
16. Bander J, Elmariah S, Aledort LM, Dlott J, Stelzer P, Halperin JL et al. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty. Thromb Haemost 2012;108:86-93.
17. van Schie MC, van Loon JE, de Maat MP, Leebeek FW. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review. J Thromb Haemost 2011;9:899-908.
18. Emeklibas N, Kammerer I, Bach J, Sack FU, Hellstern P. Preoperative hemostasis and its association with bleeding and blood component transfusion requirements in cardiopulmonary bypass surgery. Transfusion 2013;53:1226-34.
19. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Nilsson S, Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion 2008;48:2152-8.
20. Lo B, Nierich AP, Kalkman CJ, Fijnheer R. Relatively increased von Willebrand factor activity after off-pump coronary artery bypass graft surgery. Thromb Haemost 2007;97:21-6.
21. Feys HB, Canciani MT, Peyvandi F, Deckmyn H, Vanhoorelbeke K, Mannucci PM. ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Br J Haematol 2007;138:534-40.
22. Wahba A, Rothe G, Lodes H, Barlage S, Schmitz G, Birnbaum DE. Predictors of blood loss after coronary artery bypass grafting. J Cardiothorac Vasc Anesth 1997;11:824-7.
23. Leissinger C, Carcao M, Gill JC, Journeycake J, Singleton T, Valentino L. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Haemophilia 2013. doi:10.1111/hae.12254.
24. Boening A, Boedeker RH, Scheibelhut C, Rietzschel J, Roth P, Schonburg M. Anemia before coronary artery bypass surgery as additional risk factor increases the perioperative risk. Ann Thorac Surg 2011;92:805-10.
25. Kremke M, Tang M, Bak M, Kristensen KL, Hindsholm K, Andreasen JJ et al. Antiplatelet therapy at the time of coronary artery bypass grafting: a multicentre cohort study. Eur J Cardiothorac Surg 2013;44:e133-40.